This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
1 out of 7 registries used, show all original rules.
274
Check minimum number of events
274
Include endpoints None
274
Remove individuals based on genotype QC
256
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to Use of dimethyl fumarate based on the number of shared cases.
Broader endpoints:
- MS-disease / Multiple Sclerosis
- Demyelinating diseases of the central nervous system
- Autoimmune diseases related-to ILD
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 256 | 209 | 47 |
Unadjusted prevalence (%) | 0.06 | 0.09 | 0.03 |
Mean age at first event (years) | 41.58 | 41.04 | 44.01 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: MSMED_DIMETHYL_FUMARATE – Use of dimethyl fumarate
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Use of dimethyl fumarate
↥Endpoint not on priority list, no data to show.